Science & Technology
Raising cash for bioscience with Trevor Martin (Mammoth Biosciences) + Ursheet Parikh (Mayfield)
Trevor Martin started Mammoth Biosciences with the goal of using the revolutionary technology CRISPR to diagnose and cure diseases. The Stanford grad raised $268.12M to advance this goal, but like so many other companies, it all started at an accelerator. Hear from Martin and early investor, Ursheet Parikh on how Mammoth Biosciences secured early financing…
Sean W
October 6, 2022 at 1:27 am
At what stage will Mammoth look to go public? Many biotechs go public well before they have a product in the marketplace. Does Mammoth feel they need to have a certain level of revenue before going public?